Majda Dzidic1,2,3, Alex Mira2,4, Alejandro Artacho2, Thomas R Abrahamsson5, Maria C Jenmalm3, Maria Carmen Collado1. 1. Department of Biotechnology, Institute of Agrochemistry and Food Technology (IATA-CSIC), Unit of Lactic Acid Bacteria and Probiotics, Valencia, Spain. 2. Department of Health and Genomics, Center for Advanced Research in Public Health, FISABIO, Valencia, Spain. 3. Department of Clinical and Experimental Medicine, Division of Autoimmunity and Immune Regulation, Linköping University, Linköping, Sweden. 4. CIBER-ESP, Madrid, Spain. 5. Department of Clinical and Experimental Medicine and Department of Pediatrics, Linköping University, Linköping, Sweden.
Abstract
BACKGROUND: Early colonization with a diverse microbiota seems to play a crucial role for appropriate immune maturation during childhood. Breastmilk microbiota is one important source of microbes for the infant, transferred together with maternal IgA antibodies. We previously observed that allergy development during childhood was associated with aberrant IgA responses to the gut microbiota already at 1 month of age, when the IgA antibodies are predominantly maternally derived in breastfed infants. OBJECTIVE: To determine the microbial composition and IgA-coated bacteria in breastmilk in relation to allergy development in children participating in an intervention trial with pre- and post-natal Lactobacillus reuteri supplementation. METHODS: A combination of flow cytometric cell sorting and 16S rRNA gene sequencing was used to characterize the bacterial recognition patterns by IgA in breastmilk samples collected one month post-partum from 40 mothers whose children did or did not develop allergic and asthmatic symptoms during the first 7 years of age. RESULTS: The milk fed to children developing allergic manifestations had significantly lower bacterial richness, when compared to the milk given to children that remained healthy. Probiotic treatment influenced the breastmilk microbiota composition. However, the proportions of IgA-coated bacteria, the total bacterial load and the patterns of IgA-coating were similar in breastmilk between mothers of healthy children and those developing allergies. CONCLUSION: Consumption of breastmilk with a reduced microbial richness in the first month of life may play an important role in allergy development during childhood.
BACKGROUND: Early colonization with a diverse microbiota seems to play a crucial role for appropriate immune maturation during childhood. Breastmilk microbiota is one important source of microbes for the infant, transferred together with maternal IgA antibodies. We previously observed that allergy development during childhood was associated with aberrant IgA responses to the gut microbiota already at 1 month of age, when the IgA antibodies are predominantly maternally derived in breastfed infants. OBJECTIVE: To determine the microbial composition and IgA-coated bacteria in breastmilk in relation to allergy development in children participating in an intervention trial with pre- and post-natal Lactobacillus reuteri supplementation. METHODS: A combination of flow cytometric cell sorting and 16S rRNA gene sequencing was used to characterize the bacterial recognition patterns by IgA in breastmilk samples collected one month post-partum from 40 mothers whose children did or did not develop allergic and asthmatic symptoms during the first 7 years of age. RESULTS: The milk fed to children developing allergic manifestations had significantly lower bacterial richness, when compared to the milk given to children that remained healthy. Probiotic treatment influenced the breastmilk microbiota composition. However, the proportions of IgA-coated bacteria, the total bacterial load and the patterns of IgA-coating were similar in breastmilk between mothers of healthy children and those developing allergies. CONCLUSION: Consumption of breastmilk with a reduced microbial richness in the first month of life may play an important role in allergy development during childhood.
Authors: Erin C Davis; Vanessa P Castagna; David A Sela; Margaret A Hillard; Samantha Lindberg; Nicholas J Mantis; Antti E Seppo; Kirsi M Järvinen Journal: J Allergy Clin Immunol Date: 2022-09 Impact factor: 14.290
Authors: Antti E Seppo; Kevin Bu; Madina Jumabaeva; Juilee Thakar; Rakin A Choudhury; Chloe Yonemitsu; Lars Bode; Camille A Martina; Maria Allen; Sabrina Tamburini; Enrica Piras; David S Wallach; R John Looney; Jose C Clemente; Kirsi M Järvinen Journal: Allergy Date: 2021-05-14 Impact factor: 14.710
Authors: Lisa F Stinson; Melvin C L Gay; Petya T Koleva; Merete Eggesbø; Christine C Johnson; Ganesa Wegienka; Elloise du Toit; Naoki Shimojo; Daniel Munblit; Dianne E Campbell; Susan L Prescott; Donna T Geddes; Anita L Kozyrskyj Journal: Front Immunol Date: 2020-07-21 Impact factor: 7.561
Authors: Caroline E Childs; Daniel Munblit; Laurien Ulfman; Carlos Gómez-Gallego; Liisa Lehtoranta; Tobias Recker; Seppo Salminen; Machteld Tiemessen; Maria Carmen Collado Journal: Adv Nutr Date: 2021-10-01 Impact factor: 8.701